Abstract
Two series of 17 tetrahydroquinoline compounds (2,4-DAr-THQs and DSQs), in which the 4-methoxy-3- hydroxyphenyl (isovanillin) structural unit is incorporated, were tested for their potential human tumor cell growth inhibitory effect on MCF-7, SKBR-3, PC3, HeLa and for non-tumor cells (primary culture of human dermis fibroblast – control cells) for the first time. The THQ 8 is an interesting model for antitumoral drugs, displaying cytotoxic activity against MCF7, SKBR3 or PC3 (IC50 7.99 - 16.14 μM) with the selectivity index 3.4 for MCF7.
Keywords: Functionalized tetrahydroquinolines, Isoeugenol, Antitumoral agents, Lewis acid-catalyzed imino Diels-Alder reactions, Tetrahydroquinoline compounds, Antimalarial, Antioxidant, Antimycobacterial, Polyfunctionalized quinoline, Anticancer agents, Hemi-synthetic, Synthetiq agents, Imino Diels Alder cycloaddition, Ketimine precursors, HeLa (cervical epithelial carcinoma), Adriamycin, Eugenol, Quinoline derivatives, Cytotoxic activities, Tumor cancer cells, Isatin, Anilines, Reference selectivity index
Letters in Drug Design & Discovery
Title: 4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents
Volume: 7 Issue: 9
Author(s): Vladimir V. Kouznetsov, Diego R. Merchan Arenas, Francisco Arvelo, Josue S. Bello Forero, Felipe Sojo and Arturo Munoz
Affiliation:
Keywords: Functionalized tetrahydroquinolines, Isoeugenol, Antitumoral agents, Lewis acid-catalyzed imino Diels-Alder reactions, Tetrahydroquinoline compounds, Antimalarial, Antioxidant, Antimycobacterial, Polyfunctionalized quinoline, Anticancer agents, Hemi-synthetic, Synthetiq agents, Imino Diels Alder cycloaddition, Ketimine precursors, HeLa (cervical epithelial carcinoma), Adriamycin, Eugenol, Quinoline derivatives, Cytotoxic activities, Tumor cancer cells, Isatin, Anilines, Reference selectivity index
Abstract: Two series of 17 tetrahydroquinoline compounds (2,4-DAr-THQs and DSQs), in which the 4-methoxy-3- hydroxyphenyl (isovanillin) structural unit is incorporated, were tested for their potential human tumor cell growth inhibitory effect on MCF-7, SKBR-3, PC3, HeLa and for non-tumor cells (primary culture of human dermis fibroblast – control cells) for the first time. The THQ 8 is an interesting model for antitumoral drugs, displaying cytotoxic activity against MCF7, SKBR3 or PC3 (IC50 7.99 - 16.14 μM) with the selectivity index 3.4 for MCF7.
Export Options
About this article
Cite this article as:
V. Kouznetsov Vladimir, R. Merchan Arenas Diego, Arvelo Francisco, S. Bello Forero Josue, Sojo Felipe and Munoz Arturo, 4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents, Letters in Drug Design & Discovery 2010; 7 (9) . https://dx.doi.org/10.2174/157018010792929577
DOI https://dx.doi.org/10.2174/157018010792929577 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Therapeutic Strategies Targeting Vascular Redox in Human Atherosclerosis
Recent Patents on Cardiovascular Drug Discovery Subject Index To Volume 2
Current Women`s Health Reviews Cardioprotective Effects of Natural Products <i>via</i> the Nrf2 Signaling Pathway
Current Vascular Pharmacology Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Nonviral Gene Therapy and its Delivery Systems
Current Pharmaceutical Biotechnology Methylenetetrahydrofolate Reductase: Biochemical Characterization and Medical Significance
Current Pharmaceutical Design L-carnitine: Searching for New Therapeutic Strategy for Sepsis Management
Current Medicinal Chemistry Chlorella vulgaris: A Multifunctional Dietary Supplement with Diverse Medicinal Properties
Current Pharmaceutical Design Hypertension, Prehypertension and Blood Pressure Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Proteomics Studies in Oncology Towards Personalized Medicine in Public Health: Opportunities and Challenges for OMICS Research in Iran
Current Pharmacogenomics and Personalized Medicine Peripheral Vascular Disease: The Role of MR- Angiography
Current Medical Imaging Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide
Current Medicinal Chemistry Historical Observations on the Discovery of Platelets, Platelet Function Testing and the First Antiplatelet Agent
Current Drug Targets Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS
Current Pharmaceutical Biotechnology A Metabolomic Study Reveals Novel Plasma Lyso-Gb3 Analogs As Fabry Disease Biomarkers
Current Medicinal Chemistry Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
Current Alzheimer Research Cholesteryl Ester Transfer Protein: Pharmacological Inhibition for the Modulation of Plasma Cholesterol Levels and Promising Target for the Prevention of Atherosclerosis.
Current Topics in Medicinal Chemistry Novel Agents to Manage Dyslipidemias and Impact Atherosclerosis
Cardiovascular & Hematological Disorders-Drug Targets Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease
Current Medicinal Chemistry Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery